Ibandronate sodium (Heritage Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Ibandronate sodium drug offered from Heritage Pharmaceuticals Inc.. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Heritage Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | Ibandronate sodium |
SUBSTANCE NAME: | IBANDRONATE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-09-04 |
END MARKETING DATE: | 0000-00-00 |
Ibandronate sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Ibandronate sodium from Heritage Pharmaceuticals Inc. |
LABELER NAME: | Heritage Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3(mg/3mL) |
START MARKETING DATE: | 2014-09-04 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 23155-162_c33124a8-313e-4f81-a79c-2b43b4eae501 |
PRODUCT NDC: | 23155-162 |
APPLICATION NUMBER: | ANDA203987 |
Other IBANDRONATE SODIUM Pharmaceutical Manufacturers / Labelers: